Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia

This cohort study describes patterns of development, management strategies, and long-term vascular consequences of hypertension associated with ibrutinib in the non–clinical trial setting.

Detalles Bibliográficos
Autores principales: Roeker, Lindsey E., Sarraf Yazdy, Maryam, Rhodes, Joanna, Goodfriend, Julie, Narkhede, Mayur, Carver, Joseph, Mato, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902749/
https://www.ncbi.nlm.nih.gov/pubmed/31790561
http://dx.doi.org/10.1001/jamanetworkopen.2019.16326
_version_ 1783477721684246528
author Roeker, Lindsey E.
Sarraf Yazdy, Maryam
Rhodes, Joanna
Goodfriend, Julie
Narkhede, Mayur
Carver, Joseph
Mato, Anthony
author_facet Roeker, Lindsey E.
Sarraf Yazdy, Maryam
Rhodes, Joanna
Goodfriend, Julie
Narkhede, Mayur
Carver, Joseph
Mato, Anthony
author_sort Roeker, Lindsey E.
collection PubMed
description This cohort study describes patterns of development, management strategies, and long-term vascular consequences of hypertension associated with ibrutinib in the non–clinical trial setting.
format Online
Article
Text
id pubmed-6902749
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-69027492019-12-23 Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia Roeker, Lindsey E. Sarraf Yazdy, Maryam Rhodes, Joanna Goodfriend, Julie Narkhede, Mayur Carver, Joseph Mato, Anthony JAMA Netw Open Research Letter This cohort study describes patterns of development, management strategies, and long-term vascular consequences of hypertension associated with ibrutinib in the non–clinical trial setting. American Medical Association 2019-12-02 /pmc/articles/PMC6902749/ /pubmed/31790561 http://dx.doi.org/10.1001/jamanetworkopen.2019.16326 Text en Copyright 2019 Roeker LE et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Roeker, Lindsey E.
Sarraf Yazdy, Maryam
Rhodes, Joanna
Goodfriend, Julie
Narkhede, Mayur
Carver, Joseph
Mato, Anthony
Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia
title Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia
title_full Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia
title_fullStr Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia
title_full_unstemmed Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia
title_short Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia
title_sort hypertension in patients treated with ibrutinib for chronic lymphocytic leukemia
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902749/
https://www.ncbi.nlm.nih.gov/pubmed/31790561
http://dx.doi.org/10.1001/jamanetworkopen.2019.16326
work_keys_str_mv AT roekerlindseye hypertensioninpatientstreatedwithibrutinibforchroniclymphocyticleukemia
AT sarrafyazdymaryam hypertensioninpatientstreatedwithibrutinibforchroniclymphocyticleukemia
AT rhodesjoanna hypertensioninpatientstreatedwithibrutinibforchroniclymphocyticleukemia
AT goodfriendjulie hypertensioninpatientstreatedwithibrutinibforchroniclymphocyticleukemia
AT narkhedemayur hypertensioninpatientstreatedwithibrutinibforchroniclymphocyticleukemia
AT carverjoseph hypertensioninpatientstreatedwithibrutinibforchroniclymphocyticleukemia
AT matoanthony hypertensioninpatientstreatedwithibrutinibforchroniclymphocyticleukemia

Ejemplares similares